(Q44317995)

1 December 2017

title

The role of chemical fingerprinting: application to Ephedra (English)

1 reference

4-[3-(docosyloxy)-3-oxoprop-1-en-1-yl]benzoic acid

1 December 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

inferred from

reverse claim

4-[3-(Docosyloxy)-3-oxo-1-propenyl]benzoic acid

1 reference

inferred from

reverse claim

4-[3-(icosyloxy)-3-oxoprop-1-en-1-yl]benzoic acid

1 reference

inferred from

reverse claim

4-[3-(Icosyloxy)-3-oxo-1-propenyl]benzoic acid

1 reference

4

Ikhlas A Khan

1 reference

1 December 2017

Brian T Schaneberg

1

1 reference

1 December 2017

Sara Crockett

series ordinal

2

1 reference

1 December 2017

Erdal Bedir

series ordinal

3

1 reference

1 December 2017

publication date

March 2003

1 reference

16 September 2022

1 reference

1 December 2017

volume

62

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

911-918

1 reference

Chiral Gas Chromatographic Determination of Ephedrine-Type Alkaloids in Dietary Supplements Containing Má Huáng

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Challenges and opportunities confronting the botanical dietary supplement industry

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

New observations on the secondary chemistry of world Ephedra (Ephedraceae).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Simultaneous chiral analysis of methamphetamine and related compounds by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

A case of positive doping associated with a botanical food supplement.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Methamphetamine synthesis via hydriodic acid/red phosphorus reduction of ephedrine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Effect of hydroxypropyl-beta-cyclodextrin on the central stimulant activity of (-)-ephedrine and an oxazolidine prodrug in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

Hypersensitivity myocarditis associated with ephedra use.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900716-1

7 January 2021

10.1016/S0031-9422(02)00716-1

Identifiers

DOI

1 reference

1 December 2017

1 reference